© 2026 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement
<< Back To Article
Lynparza Slows Disease Progression in Women With BRCA-Related Ovarian Cancer

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

1 Comments

J. M. Jones

My Daughter has malignant pleural effusion with no measurable disease. She had many treatments of platinum both carbon and cisplatin with various combinations with minimum success. She also had Avastin and a parp inhibitor with minimum success. She is considered resist and I'm wondering if she could be eligible for any trials in the USA. .She is HRD positive if that helps. Please advise. Thank You

October 24, 2018 • PA

Hot topics

Breast Cancer
Lung Cancer
Liver Cancer
Prostate Cancer
Cancer Treatment
FIT test, colon cancer screening
Cancer Screening
Ovarian Cancer
Blood Cancers - Leukemia/Lymphoma/Multiple Myeloma

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.